The Diagnosis That Helped Me Finally Heal: Living with Bipolar Disorder as a Mental Health Professional
I thought I was the helper, not the one who needed help.
As a mental health professional, I've given many difficult diagnoses to clients. I never expected one of those diagnoses to hit so close to home.
It happened during an appointment with a high-achieving woman. A leader, someone respected in her field. I delivered the diagnosis, and I saw something shift in her eyes. She almost cried. To her, it felt like a life sentence.
But something else happened, too.
While sitting across from her, I had a quiet realization: I meet the same criteria. I'd already suspected it. Deep down, I knew. But in that moment, I felt like I was straddling two identities: the clinician and the woman silently struggling. And I couldn't ignore it any longer.
The Internal Struggle: Denial, Shame, and the Voice in My Head
I didn't accept my own diagnosis right away. I questioned everything. I thought, maybe the psychiatrist got it wrong.
I rewrote my story, convinced myself there had to be another reason. But no matter how I tried to explain it away, I couldn't ignore what I'd been through.
I thought about the younger version of me, the girl who stayed up all night dissociating. The one who went from feeling on top of the world to feeling like she was buried six feet under, sometimes overnight. The girl who felt like she never fit in, who didn't finish the career path she once dreamed of. The one who constantly questioned her worth.
That girl didn't need to be fixed. She needed to be heard. She needed compassion.
And she needed me to stop gaslighting her.
The Turning Point: Choosing Stability Over Survival
It took me six months to fully accept the diagnosis.
And even then, I fell into the classic trap: I felt 'better,' so I stopped taking my medication. I thought I could manage on my own.
But I wasn't actually managing. I was suppressing. I was reacting more, having emotional meltdowns, and pushing through life on empty.
I started to track my moods and patterns. I fought with myself daily. I even projected my fears onto my husband, convinced he just wanted me 'subdued.' But the truth was, I didn't want to lose control. I was afraid of what healing would require from me.
But eventually, I chose it.
I returned to treatment, took my medications consistently, and most importantly, I started communicating clearly.
I began naming what I needed: connection, validation, rest. I stopped pretending everything was fine.
Because 'I'm fine' is not an emotion.
Reclaiming My Identity, Purpose, and Peace
With stability came clarity. And with clarity came purpose.
I reconnected with my family. I found joy in my work again. I stopped living in survival mode and started building a life based on my values, not just my coping mechanisms.
Today, I'm a licensed psychiatric nurse practitioner, therapist, and emotional intelligence coach. I'm also the founder of Empower Mental Health, a space created to give others the kind of comprehensive care I once needed:
Therapy
Medication management
Emotional education and coaching
I've built my life – and my practice – on the belief that healing happens when you meet all parts of yourself with honesty and care.
I teach my clients how to regulate, connect, and thrive. Not in spite of their diagnosis, but with it.
You're Not Alone
Mental health diagnoses can feel scary. They can come with stigma, shame, and uncertainty. But they can also be an invitation to stop surviving and start living with intention.
Getting diagnosed was not the end of my story. It was the beginning of real healing.
If you're wondering what's 'wrong' with you, maybe it's time to start asking what your mind is trying to tell you. Trust your body. Listen to your intuition. And know that help doesn't make you weak. It makes you wise.
You're not alone. And you don't have to fake it anymore.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Overpopulation Solution: Veterinarians donating time to help strays
LEBANON — This year, an unprecedented number of stray cats have been flooding rescue facilities, calling for a viable and safe solution for these furry friends. The Lebanon Veterinary Hospital offered a solution by creating the SNIPS (Spays, Neuters Impact Populations) program, in which veterinarians are donating their time to provide spay and neuter services for rescue organizations at a small cost. According to Bernadette Orscher, VP of marketing for the network of hospitals Piper Veterinary, this crisis is the consequence of various factors. One of the factors is that for each unaltered female cat, 36 kittens can be born every year. Other factors have played a role in this crisis, like the increased costs for spay and neuter procedures going from $400 to over $1,000 in Connecticut. Economic pressure has also led to an increase in pet abandonments. 'That flywheel of unspayed and neutered animals is just going to continue to raise the number of pet abandonment numbers,' she said. 'The state now has officially recognized the overpopulation issue. So, instead of putting additional strains on town resources, we're trying to help and get ahead of it.' Although rescues get help through the State Voucher Program to finance these procedures, the number of animals in need have led many rescues to be out of vouchers before the year ended. With SNIPS, the Lebanon Veterinary Hospital is providing these procedures at a discounted rate, whether they still have these vouchers or not. In a few numbers, a dog spay cost over $800, which is reduced to $200 with the SNIPS program. For cats, the procedures start at $80. In addition to each surgery, the animals also get two vaccinations at no additional cost. 'The veterinary team is absorbing a significant amount of the cost to offer this to rescues,' she said. 'So, we're trying to make sure we can keep it as inclusive as possible and open as possible.' Throughout the summer, Piper Veterinary and the Lebanon Veterinary Hospital will be hosting programs to help animals get the medical attention they need to limit overpopulation. 'We're trying to maximize the number of animals that we're able to help and support. And that's best negotiated through rescue groups,' Orscher said. On June 9, they will have a clinic day with PAWS cat shelter and are still scheduling events to do throughout the summer. 'There's nothing harder in vet medicine than seeing discarded or unwanted pets,' said Dr. Steven Zickmann of Lebanon Veterinary Hospital. 'We have to do better, or it will never stop.'
Associated Press
15 minutes ago
- Associated Press
Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression
This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback can influence emotional brain networks relevant to depression. PALO ALTO, Calif., June 3, 2025 /PRNewswire/ -- Matter Neuroscience is pleased to announce a collaboration with Stanford Medicine's Psychiatry and Behavioral Sciences Department. The controlled, multi-arm study will enroll at least 210 depressed patients with the objective to significantly reduce clinical endpoints using real-time 7T fMRI neurofeedback in combination with the Matter protocol selectively activating key brain areas hosting distinct positive emotions. The clinical endpoints are paralleled with several molecular, emotional and behavioral biomarkers. If successful, the findings can be integrated into a full-scale clinical trial with the potential to inform future non-pharmaceutical curative therapies for depression. Professor Nolan Williams, M.D. an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab will serve as the Principal Investigator on the study. 'This study allows us to investigate how targeted emotion training, guided by real-time fMRI, may influence mood-related brain circuits,' said Dr. Williams. 'What makes this particularly interesting is the opportunity to evaluate both the neural mechanisms involved in emotion regulation and the feasibility of translating this approach into a deliverable treatment in the clinic or home one day.' Matter CEO Axel Bouchon shares, 'After we have seen positive effects in emotional wellbeing of healthy individuals in our studies in the past 4-5 years, it is just one of the most exciting studies I have witnessed in my career. Ultimately, we try to use the latest advancements in MRI technology and the patients' good memories as a personalized medicine to reduce, maybe permanently cure, their depressive symptoms.' About Matter Matter Neuroscience was founded in 2019 by Axel Bouchon and Ben Goldhirsh. Matter's mission is to use neuroscience to help people live longer, healthier, happier lives. Matter Neuroscience runs a consumer technology business ( ) and a medical business addressing healthy individuals and patients, respectively. Matter is led by CEO Axel Bouchon (Moderna, Bayer, ARCH Venture Partners.) Ben Goldhirsh (GOOD Worldwide and the Goldhirsh Foundation) serves as Matter's Chairman and Head of Product. Visit to learn more about Matter. Download the Matter app, named 'App of the Day' on Apple's App Store. Follow Matter on Instagram and Tiktok for education and inspiration for living a happier life. About the Matter Protocol Matter Neuroscience and its academic partners in Maastricht and Copenhagen have conducted several research studies successfully identifying a human map for distinct positive emotions in the brain. Using this map as a directional biomarker, a team led by Professor Rainer Goebel at the Maastricht Brain Imaging Center in the Netherlands developed a protocol that allows for training and intensifying distinct human emotions using real-time fMRI neurofeedback with autobiographical memories. View original content to download multimedia: SOURCE Matter Neuroscience
Medscape
41 minutes ago
- Medscape
Hyperinsulinemia Linked to Abnormal Uterine Bleeding
Hyperinsulinemia appears to have an early association with common causes of abnormal uterine bleeding (AUB), particularly in women with obesity, a preliminary study in Menopause found. Although preliminary, the study data suggested the opportunity for future research on potential relationships between cardiovascular disease risk factors and gynecologic disease. 'Many studies and organizational bodies have examined and asserted a relationship between polycystic ovarian syndrome (PCOS) and elevated insulin levels,' wrote investigators led by Andrea C. Salcedo, DO, MPH, of the Department of Obstetrics and Gynecology at Loma Linda University in Loma Linda, California. They noted that AUB is the most common reason for benign gynecologic consultation in the United States. Andrea C. Salcedo, DO, MPH 'After over 15 years of clinical practice , I started realizing there were several patterns in women who presented with irregular or heavy periods. Many were self-referred or sent by their primary care providers to see me to evaluate for female hormone problems,' Salcedo told Medscape Medical News . 'The majority were not in perimenopause, but they had similar risk factors for cardiovascular disease, such as obesity, hypertension, and migraine headaches.' Salcedo began to wonder whether healthcare providers are recognizing abnormal periods in reproductive age as a cardiovascular risk and using them to educate women on prevention rather than solely treating them medically or surgically. 'I believe that the theory of the uterus as an 'end organ' that receives inflammation in the same way as the heart and kidneys do in cardiovascular disease helps explain to the patient the reasons for heavy or irregular periods.' The study findings came as no surprise to her: 'They confirmed the patterns I was seeing clinically.' Hyperinsulinemia is associated with smooth blood vessel inflammation in the peripheral circulation. 'What is often under-recognized is that the uterus is made of these same blood vessels.' When the uterus is on the receiving end of inflammation, the blood vessels are damaged and do not function appropriately. The result can be uterine fibroids or heavy periods. The gynecologic expression of this inflammation can vary from person to person, she added. The Study This exploratory cross-sectional analysis of the association between hyperinsulinemia and biomarkers of metabolic syndrome in reproductive-aged women with AUB was designed to motivate future hypothesis-driven research. It was conducted from June 2019 to August 2023 at a single institution's outpatient gynecology clinics. A total of 205 premenopausal women aged 18-54 years were enrolled, including 116 with AUB and 89 control individuals with normal menstrual cycles. Approximately 40% in each group were identified as Hispanic. Participants underwent assessment for fasting insulin and additional markers of metabolic syndrome, including body mass index (BMI), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and waist-to-hip ratio. Among the findings: • Hyperinsulinemia, the main effect of interest, was a significant predictor of AUB, affecting 44.0% of the AUB group vs 33.7% of the control group, with an odds ratio of 3.0 (95% CI, 1.372-6.832; P = .0085). • Hypertension, LDL, HDL, smoking, migraines, and polyps or fibroids were all significantly associated with AUB and identified as confounders. Chronic hypertension was identified in 26% of the AUB group vs 12% of the control group. • Interestingly, including BMI in the model diminished the significance of hyperinsulinemia, suggesting overlapping or mediating pathways, the authors said. • Among metabolic markers, LDL levels were similar between groups, while HDL levels were lower in women with AUB (54.0 vs 60.0 mg/dL). • There was a nonsignificant intergroup difference in triglycerides (82.0 vs 73.5 mg/dL) and total cholesterol levels (169.0 vs 172.5 mg/dL). • Migraines were more prevalent in the AUB group (31.0% vs 11.2%), as were polyps or fibroids (45.7% vs 9.6%). Commenting on the study but not involved in it, Maureen Whelihan, MD, a gynecologist at the Center for Sexual Health and Education and Elite GYN Care of the Palm Beaches in Greenacres, Florida, called the study an interesting one, 'suggesting that before we see the effects of PCOS, a diagnosis of hyperinsulinemia can be made and managed and that hyperinsulinemia has a direct effect on microinflammatory injury to the uterus.' Maureen Whelihan, MD In her practice, women with insulin resistance and PCOS have major infertility issues. 'About 85% are obese and have lipid disorders. While this study indicates we can make a diagnosis earlier by evaluating fasting insulin, the question is, 'then what?'' she said. The ultimate remedy is diet and lifestyle modification. 'The minute patients understand they must eliminate starch and sugar to lower insulin levels and move their body a little, we lose them,' she said. 'They want a quick fix and nothing that requires them to make difficult decisions and drastic modifications. This is the hard part! We can teach them the pathophysiology all day, but they have to commit to a permanent change in the way they approach diet and exercise.' While the study findings are exploratory and preliminary, Salcedo said, they suggest that abnormal periods may have predictive value. 'In many cases, elevated fasting insulin levels, above 10 µU/mL, could be an early sign of cardiovascular and diabetes disease risk.' In this study, elevated insulin levels were associated with AUB, particularly among those with obesity. 'Therefore, when a patient sees her healthcare provider for irregular periods, it could be an excellent opportunity to discuss the known association of menstrual problems with [cardiovascular] risk factors.' Larger, longitudinal studies are needed, however, to confirm the causal mechanisms, Salcedo said.
